FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

  • U.S. Food and Drug Administration
  • October 29, 2026
  • ID: shortage-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-hospira-inc-a-pfizer-company-0409-8126-10

Drug Shortage Details

Generic NameBupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryAnalgesia/Addiction
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code0409-8126-10
Presentation & Dosage Form

Marcaine with Epinephrine, Injection, Marcaine™ 0.5% 50 mg/10 mL (5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-8126-10)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.